πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7432349

Tumor suppressor gene, p28ING5

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7432236

Vasostatin as marrow protectant

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7431931

Compositions and method for preventing reactogenicity associated with administration of im

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7427590

Neurothrophic components of the ADNF I complex

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7427671

Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7427598

Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides f

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7427394

Biodegradable poly(Ξ²-amino esters) and uses thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7425218

Nitric oxide-releasing medical devices

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7425611

Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7422755

Antimultiorganism glycoconjugate vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7419957

Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic met

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7419683

Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic ve

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7417136

Nucleic acid vaccines for prevention of flavivirus infection

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7416878

Immunogenic compositions including rough phenotype Brucella host strains and complementati

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7410771

Reagent and method for detecting a Cryptosporidium parvum sporozoite antigen

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7410644

Recombinant pox virus for immunization against tumor-associated antigens

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7407935

Ricin toxin A-chain fragment for use as a vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7408075

Synthesis of phosphocholine ester derivatives and conjugates thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7407658

Vaccines for blocking transmission of plasmodium vivax

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7407664

Peptide vaccines against group A streptococci

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7404961

Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family protei

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7402659

Thymic stromal lymphopoietin receptor molecules and uses thereof

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7402567

Treatment of disease by inducing cell apoptosis

The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7399827

Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted